A new Strategic Partenership: FACE

Fedegari Group is proud to announce the launch of FACE, a strategic joint venture with our partner ACE Technologies, an Indian company specialized in advanced engineering solutions.

This collaboration represents a significant step forward in anticipating and meeting the needs of the pharmaceutical sector in India, a constantly evolving market.

The partnership combines Fedegari’s global expertise in sterilization with ACE Technologies’ technical and service capabilities, creating an alliance focused on optimizing processes and services while delivering customized solutions to our clients.

Why FACE is a Strategic Partnership

FACE is not just a joint venture but a cornerstone of our strategic vision to build a global knowledge network. The partnership is founded on:

• Integration of Complementary Expertise: Fedegari’s global experience and ACE’s local technical support come together to tackle the challenges of the pharmaceutical sector with innovative solutions.
• Customer-Centric Approach: FACE aims to deliver an exceptional customer experience by offering tailored support and building long-lasting, trusted relationships.
• Expansion of the Global Network: FACE contributes to the growth of our knowledge network by promoting training and sharing expertise within the Indian market.

A Global Ecosystem for Innovation

FACE strengthens our commitment to creating a global ecosystem where knowledge is the driving force.

• LCE – Learning Campus Experience: The heart of our knowledge network, dedicated to developing and disseminating expertise through training centers and technological innovation.
• Fedegari Technology Centers: Laboratories where we work closely with clients to optimize processes and deliver customized solutions.
• Singapore Tech Center: A strategic hub that bridges global expertise with local market needs, fostering dialogue and innovation.

Looking to the Future

With FACE, we reinforce our presence in Asia and set new standards for sterilization in the pharmaceutical sector. This partnership is not just an opportunity for growth but a model for innovative collaboration.

With FACE, we are transforming industry challenges into opportunities, offering solutions that go beyond current limits.

Our strength lies in anticipating the future, collaborating with our clients to build a new era of sterile therapies together.

This initiative is a tangible step toward our goal of improving the lives of millions of people through cutting-edge sterile therapies. FACE represents our commitment to shaping the future of the pharmaceutical sector with creativity, courage, and dedication.